Over the last 12 months, Medpace Holdings insiders reported no purchases and 3 sales totaling $16.2M across SEC Form 4 filings.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Troendle August J.President & CEO · O·D·10% | ▼ Sale | 7,238 | $600.44 | $4.3M | -1.1% | 2 tranches |
| Jul 28, 2026 | BURWIG SUSAN EExec. VP, Operations · O | ▼ Sale | 7,500 | $600 | $4.5M | -10.6% | — |
| May 28, 2026 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. · O | ▼ Sale | 16,349 | $450 | $7.4M | -44.6% | — |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MEDP feed.